Abstract: Emerging artificial intelligence (AI) learning technologies provide new insights into energy management strategies (EMSs) for fuel cell hybrid electric vehicles (FCHEVs). However, existing ...
While announcing its quarterly results, the TCS board approved the creation of a TCS subsidiary that will focus on building a sovereign data center with a capacity of 1GW. TCS will be keeping the data ...
Contributed by Shing-Tung Yau; received January 29, 2024; accepted July 19, 2024; reviewed by Stephan Huckemann and Jingyi Jessica Li Single-cell RNA sequencing (scRNA-seq) analysis, crucial for ...
Today’s TV landscape offers more than a lifetime’s worth of choice for audiences. In total, TV audiences in the U.S. can now find content on more than 32,200 linear channels and 89 streaming video ...
Abstract: The annotation of cell types based on single-cell RNA sequencing (scRNA-seq) data is a critical downstream task in single-cell analysis, with significant implications for a deeper ...
Bolt Biotherapeutics has halved its workforce for the second time in two years as the oncology biotech delays a readout of its lead immunotherapy. The company had previously been expecting initial ...
For all the hype around artificial intelligence (AI) in health care, the biggest obstacles have often been bureaucratic, not just technical. Patient privacy laws, incompatible data systems and the ...
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Federal agents with Homeland Security Investigations discovered an additional 200,000 SIM cards at a location in New Jersey, law enforcement sources confirmed to CBS News. Agents were first tipped off ...
The spending on accommodation for An Garda Síochána members who were policing an UEFA Europa League final in May last year did not represent value for money, according to the Office of the Comptroller ...
Opus Genetics has shared data on its gene therapy in children with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps for the program. North Carolina-based Opus ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback